Tissue factor in cardiovascular diseases: molecular mechanisms and clinical implications.
about
Inhibition of acute vascular thrombosis in chimpanzees by an anti-human tissue factor antibody targeting the factor X binding siteTriglyceride-rich lipoproteins as a causal factor for cardiovascular diseaseHigh-Risk Cardiovascular Patients: Clinical Features, Comorbidities, and Interconnecting MechanismsOral direct thrombin inhibition: a double-edged sword?The prothrombotic tendency in metabolic syndrome: focus on the potential mechanisms involved in impaired haemostasis and fibrinolytic balanceRecent advances in drug eluting stentsThe role of saliva in tick feedingUltrafine carbon particle mediated cardiovascular impairment of aged spontaneously hypertensive ratsPeroxisome proliferator-activated receptor-gamma agonists suppress tissue factor overexpression in rat balloon injury model with paclitaxel infusionRapamycin regulates the expression and activity of Krüppel-like transcription factor 2 in human umbilical vein endothelial cellsEGFP-EGF1-conjugated PLGA nanoparticles for targeted delivery of siRNA into injured brain microvascular endothelial cells for efficient RNA interferenceMembrane type 1-matrix metalloproteinase/Akt signaling axis modulates TNF-α-induced procoagulant activity and apoptosis in endothelial cellsThe Syk-kinase inhibitor R406 impairs platelet activation and monocyte tissue factor expression triggered by heparin-PF4 complex directed antibodies.The Myosin II Inhibitor, Blebbistatin, Ameliorates FeCl3-induced Arterial Thrombosis via the GSK3β-NF-κB Pathway.Roles of Coagulation and fibrinolysis in angiotensin II-enhanced microvascular thrombosisDrug-eluting stentsSoluble guanylate cyclase agonists inhibit expression and procoagulant activity of tissue factorPorcine endothelial cells cocultured with smooth muscle cells became procoagulant in vitro.Mycobacterium tuberculosis infection and tissue factor expression in macrophages.Valsartan independent of AT₁ receptor inhibits tissue factor, TLR-2 and -4 expression by regulation of Egr-1 through activation of AMPK in diabetic conditions.Activated factor XI and tissue factor in chronic obstructive pulmonary disease: links with inflammation and thrombin generation.Integrative bioinformatics analysis of genomic and proteomic approaches to understand the transcriptional regulatory program in coronary artery disease pathways.Novel oral anticoagulants: focus on stroke prevention and treatment of venous thrombo-embolism.Paclitaxel induces thrombomodulin downregulation in human aortic endothelial cells.Pulsatile to-fro flow induces greater and sustained expression of tissue factor RNA in HUVEC than unidirectional laminar flow.Endothelial outgrowth cells regulate coagulation, platelet accumulation, and respond to tumor necrosis factor similar to carotid endothelial cells.Circulating endothelial cells in patients with venous thromboembolism and myeloproliferative neoplasms.Activated factor XI and tissue factor in aortic stenosis: links with thrombin generationCirculating activated factor XI and active tissue factor as predictors of worse prognosis in patients following ischemic cerebrovascular events.Uremic serum and solutes increase post-vascular interventional thrombotic risk through altered stability of smooth muscle cell tissue factor.Enhanced expression of cell-specific surface antigens on endothelial microparticles in sepsis-induced disseminated intravascular coagulation.Toll-like receptor 9 signaling regulates tissue factor and tissue factor pathway inhibitor expression in human endothelial cells and coagulation in mice.Tissue factor; from Morawitz to microparticlesSimultaneous detection of peripheral mononuclear cell and plasma tissue factor expression for prevention and treatment of ischemic cardiocerebrovascular diseasesInhibition of Thrombin With PPACK-Nanoparticles Restores Disrupted Endothelial Barriers and Attenuates Thrombotic Risk in Experimental AtherosclerosisBeyond the Mean: Quantile Regression to Explore the Association of Air Pollution with Gene-Specific Methylation in the Normative Aging StudyCholesterol enrichment of human monocyte/macrophages induces surface exposure of phosphatidylserine and the release of biologically-active tissue factor-positive microvesicles.Low-grade risk of hypercoagulable state in patients suffering from diabetes mellitus type 2Opposite regulation by PI3K/Akt and MAPK/ERK pathways of tissue factor expression, cell-associated procoagulant activity and invasiveness in MDA-MB-231 cells.Human C-reactive protein accentuates macrophage activity in biobreeding diabetic rats.
P2860
Q24627747-6E68C42B-1DA4-4C71-91BC-42360000B48DQ26745946-88EA2C97-F127-4A8B-8680-22EF633E9E20Q26774658-CDCF36E9-B120-4717-B886-8D23AD5B2D29Q26780154-CA25950E-73EB-4A55-A179-A02CBE4EA606Q27003277-52E4BB74-D1F4-4330-8DEB-57AFA3866CECQ27025538-A36AC0CE-C244-4197-880E-A1420986835FQ27490448-960257E4-8430-4B82-B5DD-BD532D24C42DQ28392608-D34EFE37-E950-4981-8BE1-2E62F4E7DBB6Q28478187-CD5BA8BE-0A0A-4DED-8A34-034FA98BF222Q28482627-8159E441-BD27-41B1-A0DE-76A4A71AC678Q28486127-D90EAF05-0F7E-460A-A4AE-0DE95339F370Q28542576-A295B27D-6889-446F-8491-71C64B2DF372Q33396756-C7D9B359-AB9F-4F03-9D00-B7DC633004E3Q33717776-BD618CBD-43DA-4EB1-87A9-1EF19A8F5237Q33934802-47715D71-092A-4B76-9823-A2EF7689EF47Q34091036-9A12C29F-9DD5-4E25-8190-DCBCA873F8C1Q34122462-AA0A3D1F-1A91-4C5A-92BA-E2B91CFD4006Q34171376-44B8558C-60AE-4BEC-8B79-B65A8C02F245Q34429846-88375775-94B5-423E-881A-C96EB89F97EAQ34571546-B79D8F0B-8744-454E-B348-67759895926BQ34590212-557D19F6-1AF5-4661-94FC-2EF2CE28CBADQ34611855-786A1D58-3195-42A7-B857-C571F0C98B92Q34627780-4209E29C-C53F-449F-AB35-ECD234AA61A7Q34698151-5B3A1C64-714C-4343-A136-73114FD5CF33Q34784582-B7CC4A75-104B-48ED-B19C-F264FC935B5CQ34938428-0B48D090-E9BB-43DD-9487-2156F3150759Q35067553-526831DA-397A-4D6D-8BB8-980ED4CFE49DQ35137668-2DA9DFAD-B94F-4B63-91EE-A18FBF82888AQ35489598-0444BBBF-25CB-42BD-AC5E-1D09C74DC345Q35532690-A149BFBD-D5A7-4FEC-9C73-8C22D251C2C5Q35566678-268B92D6-F63A-4EC4-9A13-CD7420DA925DQ35606414-7874B67C-0D0B-4E0A-ACB2-AE483A185B62Q35778603-25735EC5-AFA3-4EC6-A34C-10C7B385DA31Q35854331-3F2493AD-96E3-456E-863B-8CA983FBEE20Q35894640-41E48285-5A3A-487D-A06E-5D1BE18C3E48Q35927971-12BAB31D-E80C-4284-A903-2B8945936383Q36055034-5E24F72B-24AF-4F0D-893B-8FF7C01339D6Q36059272-A94D0734-2DB9-4C8D-BBFC-6F5B9BE4CC59Q36088261-E7E2BD70-9EAC-4AE7-ABAC-EEBE7F169A58Q36113661-03ABD3F0-866C-4AF3-BA26-30695D9A38B8
P2860
Tissue factor in cardiovascular diseases: molecular mechanisms and clinical implications.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Tissue factor in cardiovascular diseases: molecular mechanisms and clinical implications.
@ast
Tissue factor in cardiovascular diseases: molecular mechanisms and clinical implications.
@en
type
label
Tissue factor in cardiovascular diseases: molecular mechanisms and clinical implications.
@ast
Tissue factor in cardiovascular diseases: molecular mechanisms and clinical implications.
@en
prefLabel
Tissue factor in cardiovascular diseases: molecular mechanisms and clinical implications.
@ast
Tissue factor in cardiovascular diseases: molecular mechanisms and clinical implications.
@en
P1433
P1476
Tissue factor in cardiovascular diseases: molecular mechanisms and clinical implications.
@en
P2093
Felix C Tanner
Jan Steffel
P304
P356
10.1161/CIRCULATIONAHA.105.567297
P407
P577
2006-02-01T00:00:00Z